AIG
ITOS

American International Group’s iTeos Therapeutics ITOS Stock Holding History

American International Group’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,213
Closed -$167K – 1344
2024
Q1 		$167K Sell
12,213
-105
-0.9% -$1.14K ﹤0.01% 2249
2023
Q4 		$135K Sell
12,318
-1,361
-10% -$13.5K ﹤0.01% 2386
2023
Q3 		$150K Buy
13,679
+379
+3% +$4.85K ﹤0.01% 2274
2023
Q2 		$176K Buy
13,300
+390
+3% +$5.56K ﹤0.01% 2246
2023
Q1 		$176K Buy
12,910
+50
+0.4% +$896 ﹤0.01% 2190
2022
Q4 		$251K Sell
12,860
-103
-0.8% -$2.01K ﹤0.01% 2017
2022
Q3 		$247K Buy
12,963
+456
+4% +$10.5K ﹤0.01% 2038
2022
Q2 		$258K Buy
12,507
+944
+8% +$22.4K ﹤0.01% 2020
2022
Q1 		$372K Buy
11,563
+830
+8% +$30.2K ﹤0.01% 1890
2021
Q4 		$500K Sell
10,733
-321
-3% -$10.7K ﹤0.01% 1811
2021
Q3 		$298K Sell
11,054
-263
-2% -$6.88K ﹤0.01% 2181
2021
Q2 		$290 Sell
11,317
-185
-2% -$4.41K ﹤0.01% 2272
2021
Q1 		$393 Buy
11,502
+4,990
+77% +$180K ﹤0.01% 1961
2020
Q4 		$220 Buy
6,512
+121
+2% +$3.2K ﹤0.01% 2233
2020
Q3 		$158K Buy
+6,391
New +$172K ﹤0.01% 2277

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American International Group's ITOS Position: Q2 2024 in Review

American International Group sold out of iTeos Therapeutics (ITOS) in Q2 2024, closing a stake of 12,213 shares — an estimated $167K sold.

American International Group first reported a position in ITOS in Q3 2020 and held it in 15 quarters. The position peaked at $500K in Q4 2021. 137 funds tracked by Wall St. Rank hold ITOS as of Q2 2024.

  • American International Group reported no remaining iTeos Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 12,213 iTeos Therapeutics shares in Q2 2024, an estimated $167K.
  • American International Group first reported a position in iTeos Therapeutics in Q3 2020 and held it in 15 quarters.
  • American International Group's iTeos Therapeutics position peaked at $500K in Q4 2021.
  • 137 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.